Medical ceramics are advanced ceramics that are employed in different healthcare applications and processes and are by and large bio compatible, strong and very durable. Being made from inorganic non-metallic compounds like alumina, zirconia and hydroxyapatite, these materials have been designed to cope up with the challenges of medical implants and devices. Wear resistance, corrosion resistance and mechanical strength are important for the medical ceramics that are used for implantation and should have long term functionality and should be safe to use for patients.
Across Europe, medical ceramics have been widely applied in a number of sensitive purposes. In dentistry, they are used mainly in crowns, bridges, and dental implants because of a beautiful appearance and the ability to withstand mechanical stress. Total hip and knee replacements incorporate medical ceramics to offer durable solutions, which experience low wear. Furthermore, Europe’s healthcare industry utilizes medical ceramics in minimally invasive surgical instruments and diagnostic imaging equipment; the high performance of ceramics affording better treatment to patients and enhanced surgical delicacy.
August 2023, Lithoz GmbH, Vienna, Austria, and Himed, New York, USA, have signed a research partnership to develop medical-grade bioceramics focusing on biocompatible calcium phosphates for additive manufacturing.
In July 2022, Surgeons in Europe now have access to Cerhum’s MyBone, a patient-specific 3D-printed bone, to treat patients with severe facial deformations. This 3D-printed bone is made of hydroxyapatite, a calcium phosphate that is the main mineral component of natural bone. MyBone is 3D printed with a porous structure created by Cerhum, a medical device company based in Liège, Belgium.
Across Europe, medical ceramics have been widely applied in a number of sensitive purposes. In dentistry, they are used mainly in crowns, bridges, and dental implants because of a beautiful appearance and the ability to withstand mechanical stress. Total hip and knee replacements incorporate medical ceramics to offer durable solutions, which experience low wear. Furthermore, Europe’s healthcare industry utilizes medical ceramics in minimally invasive surgical instruments and diagnostic imaging equipment; the high performance of ceramics affording better treatment to patients and enhanced surgical delicacy.
Growth Driver of the Europe Medical Ceramic Market
Advancements in Medical Technology
The European medical ceramic market is highly dynamic due to the ever-evolving developments of medical technologies. Advancements in materials sciences have seen high performance ceramics being developed with new characteristics like, biocompatibility, strength etc. These developments have allowed the development and fabrication of better and longer-lasting medical implants and devices, which overall enhances the patient’s welfare. The latest technologies such as 3D printing and other methods of production have opened up more uses of medical ceramics across the various sub specialties in medicine. For instance, a high-quality and long-wearing medical solution is a current global need, as the development of medical technologies remains a chief influence to market growth. April 2023, Aldena Therapeutics Inc. and Empa have received a CHF 600,000 from InnoSuisse to jointly work in research for the new skin delivery microneedle particles in dermatology.Rising Geriatric Population in Europe
One of the major factors driving the medical ceramic market in Europe is the increased geriatric population. There is an increased demand for medical implants and devices as the aged population continues to grow due to various diseases which may include joint pullout, bone breakage among others. Orthopedic and dental implant applications are particularly important in the field of medical ceramics because of their high mechanical strengths and the bio-equivalent characteristics of several ceramics with human tissues. Increased numbers of surgical operations and replacement among elders involving such parts as hip and knee implants always keeps demand for high quality medical ceramics on the rise. The steady increase into the proportion of aged people in the population is supposed to contribute towards the flow of this market as stakeholders in the health industry adjust in an attempt to cater for this becoming population. According to the estimate made by Eurostat, in January 2023, the Population of Europe’s Union was 448.8 million people, significantly over one fifth (21.3%) were 65 years old and over.Growing Prevalence of Chronic Diseases and diabetes in Europe
The rise in incidence of chronic ailments in the Europe has ensured that the medical ceramics market receives a tremendous boost. Chronic diseases like osteoporosis, arthritis, and cardiovascular diseases, for instance, necessitate complex treatment consisting of implants and prosthetics developed from medical ceramics. These materials are appreciated for their stability, non-toxicity and durability; therefore, they are appropriate for chronic diseases. Given this change, there is a stark need to both synthesize and apply sound medical ceramics to positively transform the health of patients suffering from extraordinary chronic diseases. Medical ceramics will increase in size as chronic diseases are on the rise; therefore, the trend will help the market to grow. Data on long-standing (chronic) health problems are based on the repeated-on health included; 36.1% of people in the EU had one or several long-standing (chronic) health problems in 2022.Germany Medical Ceramic Market
Germany is one of the biggest markets in Europe for medical ceramics mainly because of the well-developed health care system and emphasis on the use of technology. Such technical advances are well embraced and enjoyed from the market leadership by Germany in the medical technology and high-quality healthcare standards. Bioceramics such as alumina and zirconia are health-care ceramics that find extensive application in dental implants, orthopedic applications, and surgical tools. The attitude of the population to preserve the health and constant search for better ways to solve the problems that arise with the help of advanced technologies, an increase in the number of individuals with chronic diseases and an aging population directly contribute to the market growth. Germany has always focused on the research and development of the products which along with their strong manufacturing sector has boosted the demand for the medical ceramic in the region. The country’s goal to incorporate the use of technological solutions and enhancing the quality of services leads to innovation and advancement of the market in this segment. In April year 2024, Kyocera decided to form another new company, KYOCERA Fine ceramics Medical GmbH (KFMG), as the firm expanding its business in the European market.France Medical Ceramic Market
France’s medical ceramic market is experiencing steady growth, bolstered by the country’s robust healthcare system and commitment to medical innovation. Medical ceramics, such as zirconia and alumina, are increasingly used in dental implants, orthopedic devices, and surgical tools due to their superior biocompatibility and mechanical strength. The market benefits from France’s strong emphasis on research and development, which fosters ceramic materials and applications advancements. Additionally, the rising prevalence of chronic diseases and an aging population contribute to increased demand for durable and effective medical solutions. France’s well-established medical device industry and its focus on integrating advanced technologies further support the expansion of the medical ceramic market, making it a significant player in Europe’s healthcare sector.European Medical Ceramic Company Analysis
The top companies in the European Medical Ceramic Market are CeramTec GmbH, NGK Spark Plug Co.Ltd, 3M, Kyocera Corporation, Morgan Advanced Materials, DSM, Straumann, and BioMérieux SA.European Medical Ceramic Company News
In June 2024, CeramTec will introduce a new product called Sinalit®, coinciding with the PCIM Europe trade fair in Nuremberg. This new product is a silicon nitride-based substrate, expanding CeramTec's existing portfolio.August 2023, Lithoz GmbH, Vienna, Austria, and Himed, New York, USA, have signed a research partnership to develop medical-grade bioceramics focusing on biocompatible calcium phosphates for additive manufacturing.
In July 2022, Surgeons in Europe now have access to Cerhum’s MyBone, a patient-specific 3D-printed bone, to treat patients with severe facial deformations. This 3D-printed bone is made of hydroxyapatite, a calcium phosphate that is the main mineral component of natural bone. MyBone is 3D printed with a porous structure created by Cerhum, a medical device company based in Liège, Belgium.
Material Types - Market is divided into 4 Viewpoints
- Bioinert
- Bioactive
- Bioresorbable
- Piezo Ceramics
Application - Market is divided into 4 Viewpoints
- Surgical Instruments
- Plastic Surgery
- Orthopedic application
- Dental Application
Countries - Market is divided into 15 Viewpoints
- France
- Germany
- Italy
- Spain
- United Kingdom
- Belgium
- Netherlands
- Russia
- Poland
- Greece
- Norway
- Romania
- Bulgaria
- Portugal
- Rest of Europe
Key players have been covered from 3 Viewpoints:
- Overviews
- Key Person
- Recent Developments & Strategies
- Product Portfolio & Product Launch in Last 1 Year
- Revenue
Key Players Analysis
- CeramTec GmbH
- NGK Spark Plug Co.Ltd
- 3M
- Kyocera Corporation
- Morgan Advanced Materials
- DSM
- Straumann
- BioMérieux SA
Table of Contents
1. Introduction2. Research & Methodology3. Executive Summary5. Europe Medical Ceramics Market
4. Market Dynamics
6. Market Share -Europe Medical Ceramics Market
7. Material Types - Europe Medical Ceramics Market
8. Application -Europe Medical Ceramics Market
9. Countries - Europe Medical Ceramic Market
10. Porter's Five Forces Analysis
11. SWOT Analysis
12. Key Players Analysis
Companies Mentioned
- CeramTec GmbH
- NGK Spark Plug Co.Ltd
- 3M
- Kyocera Corporation
- Morgan Advanced Materials
- DSM
- Straumann
- BioMérieux SA
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | October 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 4.27 Billion |
| Forecasted Market Value ( USD | $ 6.88 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 8 |
